CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today announced it will host a conference call and live audio webcast on May 7, 2015, at 8:30 a.m. ET to report first quarter 2015 financial results.
Help employers find you! Check out all the jobs and post your resume.
